This contract expires in 140 days (Jan 31, 2027).

Browse related active opportunities

FIRM FIXED PRICENO SET ASIDE USED.

ROCHE DIAGNOSTICS CORPORATION - RAPID MOLECULAR POINT OF CARE TESTING

PIID: 36C25926N0224
Signed Date: Jan 30, 2026Effective Date: Feb 1, 2026End Date: Closes in 140 days
Award $
$442K
Vendor
ROCHE DIAGNOSTICS CORPORATION
NAICS
334516
Signed Date
Jan 30, 2026

Key Details

Dollars Obligated
$441,830
Base & All Options
$441,830
Awarding Sub-Agency
Department of Veterans Affairs
Product Service Code
6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Extent Competed
COMPETED UNDER SAP
Number of Offers
4
Place of Performance
OKLAHOMA CITY, OK, 731045007, CD-OK-05

Description

RAPID MOLECULAR POINT OF CARE TESTING

Context & Analysis

On Jan 30, 2026, Department of Veterans Affairs obligated $441,830 to ROCHE DIAGNOSTICS CORPORATION for rapid molecular point of care testing. The award is classified under NAICS 334516 — ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING and issued as a firm fixed price contract. Competition extent: competed under sap with 4 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in OKLAHOMA CITY, OK. The contract is scheduled through Jan 31, 2027 — approximately 5 months remaining. This award is one of several similar procurements from Department of Veterans Affairs under NAICS 334516 — related awards are listed below.

Contractor Information

UEI: JDMDFEZBYH36
CAGE Code: 51169
Location: INDIANAPOLIS, IN
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related